INDGNIndegene Limited
Healthcare · Health Information Services · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
The picture
- • Revenue growth: 32.8% YoY
- • Debt/Equity: 0.05
- • Promoter holding: 55.7%
- • RSI: 55
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 59%)
Bull case
- • Revenue growth: 32.8% YoY
- • Debt/Equity: 0.05
- • Promoter holding: 55.7%
- • RSI: 55
Bear case
- • Profit growth: -32.3% YoY
- • Dividend yield: 0.00%
- • MACD: bearish
- • Trend strength (ADX): 15
Key risks
- • Profit growth: -32.3% YoY
- • Dividend yield: 0.00%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹20.28). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.